palladium has been researched along with Urination Disorders in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, G; Damato, AL; Debonis, D; Gewanter, R; Kollmeier, MA; McBride, S; Mychalczak, B; Varghese, M; Zelefsky, MJ; Zhang, Z | 1 |
| Cohen, GN; Folkert, MR; Hathout, L; Kollmeier, MA; Yamada, Y; Zelefsky, MJ | 1 |
| Burri, RJ; Stock, RG; Stone, NN; Unger, P | 1 |
| Crook, J | 1 |
| Blacksburg, S; Forsythe, K; Stock, RG; Stone, N | 1 |
| Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Wallner, KE | 2 |
| Momma, T; Ohashi, T; Saito, S; Toya, K; Yorozu, A | 1 |
| Carey, B; Swift, S | 1 |
| Badalament, R; Burgers, J; Hall, SA; Nag, S; Scaperoth, DD | 1 |
| DeWyngaert, JK; Lavagnini, P; Stock, RG; Stone, NN; Unger, PD | 1 |
| Ashley, R; Gelblum, DY; Leibel, S; Potters, L; Waldbaum, R; Wang, XH | 1 |
| Butler, WM; Dorsey, AT; Lief, JH; Merrick, GS | 1 |
| Anscher, MS; Bowen, MG; Buckley, NJ; Chou, RH; Clough, RW; Das, SK; Dodge, RK; Ingram, SS; Joyner, RE; Kang, HL; Kang, SK; Kim, JH; Montana, GS; Sarmina, I; Steffey, BA; Whitehurst, AW; Zhou, SM | 1 |
2 review(s) available for palladium and Urination Disorders
| Article | Year |
|---|---|
The role of brachytherapy in the definitive management of prostate cancer.
Topics: Adenocarcinoma; Biopsy; Brachytherapy; Combined Modality Therapy; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Organs at Risk; Palladium; Patient Selection; Prostatic Neoplasms; Quality Assurance, Health Care; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Randomized Controlled Trials as Topic; Tomography, X-Ray Computed; Urination Disorders | 2011 |
The current role of imaging for prostate brachytherapy.
Topics: Adenocarcinoma; Biomarkers, Tumor; Brachytherapy; Drug Implants; Fluoroscopy; Follow-Up Studies; Forecasting; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neoplasm Recurrence, Local; Organ Size; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiology, Interventional; Radiopharmaceuticals; Radiotherapy Dosage; Tumor Burden; Ultrasonography; Ultrasound, High-Intensity Focused, Transrectal; Urination Disorders | 2007 |
2 trial(s) available for palladium and Urination Disorders
| Article | Year |
|---|---|
Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy.
Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Biopsy; Brachytherapy; Doxazosin; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Postoperative Complications; Prazosin; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention; Urination Disorders | 2002 |
Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Biopsy; Brachytherapy; Combined Modality Therapy; Erectile Dysfunction; Follow-Up Studies; Humans; Iodine Radioisotopes; Life Tables; Male; Middle Aged; Neoplasm Staging; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiotherapy Dosage; Treatment Outcome; Ultrasonography; Urination Disorders | 1996 |
10 other study(ies) available for palladium and Urination Disorders
| Article | Year |
|---|---|
Low-Dose-Rate Brachytherapy Combined With Ultrahypofractionated Radiation Therapy for Clinically Localized, Intermediate-Risk Prostate Cancer: Results From a Prospective Trial.
Topics: Aged; Brachytherapy; Humans; Male; Middle Aged; Organs at Risk; Palladium; Penile Erection; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Radiation Dose Hypofractionation; Radiation Injuries; Radioisotopes; Rectum; Seminal Vesicles; Urination Disorders | 2020 |
Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning.
Topics: Aged; Analysis of Variance; Area Under Curve; Brachytherapy; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiotherapy Dosage; Retrospective Studies; ROC Curve; Urinary Bladder; Urination Disorders | 2014 |
Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer.
Topics: Aged; Analysis of Variance; Brachytherapy; Erectile Dysfunction; Follow-Up Studies; Humans; Iodine Radioisotopes; Lymph Node Excision; Male; Middle Aged; Palladium; Pelvis; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Salvage Therapy; Treatment Outcome; Urination Disorders | 2010 |
Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
Topics: Aged; Aged, 80 and over; Brachytherapy; Chi-Square Distribution; Combined Modality Therapy; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Quality of Life; Radioisotopes; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Rectal Diseases; Regression Analysis; Retrospective Studies; Surveys and Questionnaires; Urination Disorders | 2012 |
Long-term urinary quality of life after permanent prostate brachytherapy.
Topics: Aged; Analysis of Variance; Brachytherapy; Case-Control Studies; Follow-Up Studies; Humans; Iodine Radioisotopes; Linear Models; Male; Middle Aged; Palladium; Prostatic Neoplasms; Quality of Life; Radioisotopes; Urinary Incontinence; Urinary Retention; Urination Disorders | 2003 |
Acute urinary morbidity following I-125 prostate brachytherapy.
Topics: Aged; Aged, 80 and over; Brachytherapy; Combined Modality Therapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Japan; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radiopharmaceuticals; Urinary Tract; Urination Disorders | 2005 |
Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration.
Topics: Aged; Aged, 80 and over; Brachytherapy; Follow-Up Studies; Foreign-Body Migration; Humans; Lung; Male; Middle Aged; Neoplasm Staging; Palladium; Prostatic Neoplasms; Urination Disorders | 1995 |
Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.
Topics: Aged; Aged, 80 and over; Area Under Curve; Brachytherapy; Follow-Up Studies; Hematuria; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Ultrasonography, Interventional; Urination Disorders | 1999 |
Temporal resolution of urinary morbidity following prostate brachytherapy.
Topics: Adrenergic alpha-Antagonists; Aged; Brachytherapy; Carcinoma; Humans; Iodine Radioisotopes; Male; Multivariate Analysis; Palladium; Prostatic Neoplasms; Urinary Catheterization; Urination Disorders | 2000 |
Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method.
Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Analysis of Variance; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Logistic Models; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Urination Disorders | 2001 |